GastroFISH™ is the first tissue-based fluorescence in situ hybridization (FISH) test for the detection of chromosomal anomalies associated with colon cancer.

GastroFISH™ is the first tissue-based fluorescence in situ hybridization (FISH) test for the detection of chromosomal anomalies associated with colon cancer. “We are excited to be the first laboratory to offer GastroFISH for the colon. Using current histological techniques, identifying adenomas with a high risk for progression to cancer is not possible.

RICHMOND, Va.—-GastroFISH™ is the first tissue-based fluorescence in situ hybridization test for the detection of chromosomal anomalies associated with colon cancer.

GastroFISH™ is the first tissue-based fluorescence in situ hybridization (FISH) test for the detection of chromosomal anomalies associated with colon cancer.

Online Software aids early detection of colorectal cancer . ThomasNet Industrial News Room (press release) ..